CAPG and breast cancer: Univariate analysis demonstrated that high CAPG expression in cancer tissue (HR=3.746; 95% CI: 1.157-12.134; p=0.028), along with tumor stage (HR=1.982; 95% CI: 1.194-3.292; p=0.008) and axillary lymph node stage 3 (HR=3.782; 95% CI: 1.521-9.403; p=0.004) were significant unfavorable prognostic factors for DFS in BC patients (Table S2).